Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Published:2018-12 Issue: Volume:105 Page:88-102
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mitchell Emma L.,Lau Peter Kar Han^ORCID,Khoo Chloe,Liew David^ORCID,Leung Jessica,Liu Bonnia,Rischin Adam,Frauman Albert G.,Kee Damien,Smith Kortnye,Brady Benjamin,Rischin Danny,Gibson Andrew,Mileshkin Linda,Klein Oliver,Weickhardt Andrew,Arulananda Surein,Shackleton Mark,McArthur Grant,Östör Andrew,Cebon Jonathan^ORCID,Solomon Benjamin,Buchanan Russell RC.,Wicks Ian P.,Lo Serigne^ORCID,Hicks Rodney J.,Sandhu Shahneen

Funder

Pfizer

Bristol-Myers Squibb

Roche

Celgene

Ventana

Amgen

Genentech

Merck

Regeneron

Tolmar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2017

2. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

3. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

4. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma;Weber;J Clin Oncol,2017

5. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper;Champiat;Ann Oncol,2016

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease;European Journal of Cancer;2024-08

2. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms;Autoimmunity Reviews;2024-07

3. Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica;Rheumatic Disease Clinics of North America;2024-05

4. Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis;BMC Cancer;2024-04-17

5. PET/Computed Tomography Transformation of Oncology;PET Clinics;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3